APO RESEARCH · REPORT
Narcolepsy Drug
Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.
Product & engineering
Understand the product.
Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.
The narcolepsy drug is the drug to treat narcolepsy.
Selected research
Industry Research
Narcolepsy Drug Industry Research Report 2026
Market perspective
Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.
The narcolepsy drug is the drug to treat narcolepsy.
Market competition is concentrated. Jazz Pharmaceuticals, Teva Pharmaceutical, Novartis and Mylan. are the leaders of the industry, with about 91% market shares.
Read the full market overview
Europe is the largest consumption place, with a consumption market share nearly 58%. Following Europe, USA is the second largest consumption place with the consumption market share of 29%.
Report Scope
This report quantifies the global Narcolepsy Drug market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Narcolepsy Drug Market by Company
Jazz Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
Narcolepsy Drug Segment by Type
Antioxidants Type
Stimulants Type
Others
Narcolepsy Drug Segment by Application
Daytime Extreme Sleepiness
Cataplexia
Others
Narcolepsy Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Narcolepsy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Narcolepsy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Narcolepsy Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Narcolepsy Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Narcolepsy Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Narcolepsy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antioxidants Type
- Stimulants Type
- Others
Applications
- Daytime Extreme Sleepiness
- Cataplexia
- Others
Companies covered
- Jazz Pharmaceuticals
- Teva Pharmaceutical
- Novartis
- Mylan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Narcolepsy Drug Market Size (2021-2032)
- 2.2.2 Global Narcolepsy Drug Sales (2021-2032)
- 2.2.3 Global Narcolepsy Drug Market Average Price (2021-2032)
- 2.3 Narcolepsy Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antioxidants Type
- 2.3.3 Stimulants Type
- 2.3.4 Others
- 2.4 Narcolepsy Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Daytime Extreme Sleepiness
- 2.4.3 Cataplexia
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Narcolepsy Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Narcolepsy Drug Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Narcolepsy Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Narcolepsy Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Narcolepsy Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Narcolepsy Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Narcolepsy Drug, Product Type & Application
- 3.8 Global Manufacturers of Narcolepsy Drug, Established Date
- 3.9 Global Narcolepsy Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Jazz Pharmaceuticals
- 4.1.1 Jazz Pharmaceuticals Company Information
- 4.1.2 Jazz Pharmaceuticals Business Overview
- 4.1.3 Jazz Pharmaceuticals Narcolepsy Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Jazz Pharmaceuticals Narcolepsy Drug Product Portfolio
- 4.1.5 Jazz Pharmaceuticals Recent Developments
- 4.2 Teva Pharmaceutical
- 4.2.1 Teva Pharmaceutical Company Information
- 4.2.2 Teva Pharmaceutical Business Overview
- 4.2.3 Teva Pharmaceutical Narcolepsy Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Teva Pharmaceutical Narcolepsy Drug Product Portfolio
- 4.2.5 Teva Pharmaceutical Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Narcolepsy Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Narcolepsy Drug Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Narcolepsy Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Narcolepsy Drug Product Portfolio
- 4.4.5 Mylan Recent Developments
5 Global Narcolepsy Drug Market Scenario by Region
- 5.1 Global Narcolepsy Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Narcolepsy Drug Sales by Region: 2021-2032
- 5.2.1 Global Narcolepsy Drug Sales by Region: 2021-2026
- 5.2.2 Global Narcolepsy Drug Sales by Region: 2027-2032
- 5.3 Global Narcolepsy Drug Revenue by Region: 2021-2032
- 5.3.1 Global Narcolepsy Drug Revenue by Region: 2021-2026
- 5.3.2 Global Narcolepsy Drug Revenue by Region: 2027-2032
- 5.4 North America Narcolepsy Drug Market Facts & Figures by Country
- 5.4.1 North America Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Narcolepsy Drug Sales by Country (2021-2032)
- 5.4.3 North America Narcolepsy Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Narcolepsy Drug Market Facts & Figures by Country
- 5.5.1 Europe Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Narcolepsy Drug Sales by Country (2021-2032)
- 5.5.3 Europe Narcolepsy Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Narcolepsy Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Narcolepsy Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Narcolepsy Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Narcolepsy Drug Market Facts & Figures by Country
- 5.7.1 South America Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Narcolepsy Drug Sales by Country (2021-2032)
- 5.7.3 South America Narcolepsy Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Narcolepsy Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Narcolepsy Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Narcolepsy Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Narcolepsy Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Narcolepsy Drug Sales by Type (2021-2032)
- 6.1.1 Global Narcolepsy Drug Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Narcolepsy Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Narcolepsy Drug Revenue by Type (2021-2032)
- 6.2.1 Global Narcolepsy Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Narcolepsy Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Narcolepsy Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Narcolepsy Drug Sales by Application (2021-2032)
- 7.1.1 Global Narcolepsy Drug Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Narcolepsy Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Narcolepsy Drug Revenue by Application (2021-2032)
- 7.2.1 Global Narcolepsy Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Narcolepsy Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Narcolepsy Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Narcolepsy Drug Value Chain Analysis
- 8.1.1 Narcolepsy Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Narcolepsy Drug Production Mode & Process
- 8.2 Narcolepsy Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Narcolepsy Drug Distributors
- 8.2.3 Narcolepsy Drug Customers
9 Global Narcolepsy Drug Analyzing Market Dynamics
- 9.1 Narcolepsy Drug Industry Trends
- 9.2 Narcolepsy Drug Industry Drivers
- 9.3 Narcolepsy Drug Industry Opportunities and Challenges
- 9.4 Narcolepsy Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst